Related Experiment Video
Updated: Dec 4, 2025
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
LXA4 protects against hypoxic-ischemic damage in neonatal rats by reducing the inflammatory response via the
Jin-Jin Zhu1, Bin-Yuan Yu1, Chang-Chang Fu1
1Department of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
Insights
Lipoxin A4 (LXA4) shows neuroprotective effects against neonatal hypoxic-ischemic brain injury. This study demonstrates LXA4 reduces brain damage, inflammation, and promotes neuronal survival via the IκB/NF-κB pathway.
Area of Science:
- Neuroscience
- Neonatal Medicine
- Inflammation Research
Background:
- Neonatal hypoxic-ischemic (HI) brain injury causes severe disability and death, with limited treatment options.
- Lipoxin A4 (LXA4), an endogenous lipid mediator, is known for anti-inflammatory properties but its role in the nervous system is understudied.
Purpose of the Study:
- To investigate the neuroprotective effects of LXA4 on neonatal HI brain damage in a rat model.
- To elucidate the underlying mechanisms of LXA4's action in the context of HI brain injury.
Main Methods:
- Establishment of a neonatal rat model of hypoxic-ischemic brain injury.
- Administration of LXA4 intervention to assess its impact on brain injury markers.
- In vitro experiments to evaluate LXA4's effects on neuronal insults, apoptosis, and inflammatory factors.
- Analysis of the IκB/NF-κB signaling pathway activation.
Main Results:
- LXA4 intervention reduced cerebral edema, infarct volume, and inflammatory responses in HI rats.
- LXA4 maintained blood-brain barrier integrity and promoted recovery of neuronal function and tissue structure.
- In vitro, LXA4 protected neurons from oxygen-glucose deprivation, reduced inflammatory factors, inhibited apoptosis, and promoted neuronal survival.
- LXA4 attenuated HI-induced activation of inhibitor kappa B (IκB) and degradation of nuclear factor-κB (NF-κB).
Conclusions:
- LXA4 exerts significant neuroprotection against neonatal HI brain damage.
- The protective effects of LXA4 are mediated through the IκB/NF-κB signaling pathway.
- LXA4 holds potential for therapeutic strategies targeting neuroinflammation, blood-brain barrier integrity, and neuronal apoptosis in neonatal HI brain injury.
Abstract:
Hypoxia and the resultant decreases in cerebral blood flow in the perinatal period can lead to neonatal hypoxic-ischemic (HI) brain injury, which can, in turn, cause severe disability or even death. However, the efficacy of current treatment strategies remains limited. Several studies have demonstrated that lipoxin A4 (LXA4), as one of the earliest types of endogenous lipid mediators, can inhibit the accumulation of neutrophils, arrest inflammation, and promote the resolution of inflammation. However, research on LXA4 in the nervous system has rarely been carried out. In the present study, we sought to investigate the protective effect of LXA4 on HI brain damage in neonatal rats, as well as the underlying mechanisms. Through experiments conducted using an HI animal model, we found that the LXA4 intervention promoted the recovery of neuronal function and tissue structure following brain injury while maintaining the integrity of the blood-brain barrier in addition to reducing cerebral edema, infarct volume, and inflammatory responses. Our results suggest that LXA4 interfered with neuronal oxygen-glucose deprivation insults, reduced the expression of inflammatory factors, inhibited apoptosis, and promoted neuronal survival in vitro. Finally, the LXA4 intervention attenuated HI-induced activation of inhibitor kappa B (IκB) and degradation of nuclear factor-κB (NF-κB). In conclusion, our data suggest that LXA4 exerts a neuroprotective effect against neonatal HI brain damage through the IκB/NF-κB pathway. Our findings will help inform future studies regarding the effects of LXA4 on neuroinflammation, blood-brain barrier integrity, and neuronal apoptosis.
